HIGHLIGHTS
- who: Pan Xu and colleagues from the Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Jiaotong, Jiaotong, China have published the research work: MOBT Alleviates Pulmonary Fibrosis through an lncITPF-hnRNP-l-Complex-Mediated Signaling Pathway, in the Journal: Molecules 2022, 27, 5336. of /2022/
- what: The authors demonstrate the anti-pulmonary fibrosis of 3-(4-methoxyphenyl)-4-oxo-4H-1-benzopyran-7yl(αS)-α 3 4-trihydroxybenzenepropanoate (MOBT) in mice and a cell model induced by bleomycin and transforming growth factor-β1. The study shows that MOBT alleviated pulmonary fibrosis through . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.